Search
Now showing items 1-1 of 1
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
Background
Although chemo-immunotherapy has led to an improved overall survival for most B-cell lymphoma types, relapsed and refractory disease remains a challenge. The malaria drug artesunate has previously ...